David Stein
Senior Director, Global Medical Operations, Global Clinical Development Regeneron Pharmaceuticals
David Stein serves as the Head of Managed Access Programs at Regeneron, bringing over 28 years of expertise in Clinical Trial Management and Medical Affairs. His work reflects a deep commitment to advancing science, addressing serious unmet medical needs, and making a meaningful difference in people’s lives.
Seminars
Thursday 26th March 2026
The Role of Compassionate Use & Expanded Access Programs in Epidemics & Pandemics: A Look at COVID-19 & Ebola
11:30 am
- Examine how Compassionate Use and Expanded Access Programs operate in fast-moving outbreaks, using Ebola and COVID-19 to illustrate the clinical, regulatory, and ethical landscape
- Compare two approaches our team deployed in each outbreak, explaining when and why they were chosen, how they were implemented, and their impact on patient access
